Investment House LLC Bristol Myers Squibb CO Transaction History

Investment House LLC

$1.81 Billion
Q4 2024

A detailed history of Investment House LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investment House LLC holds 51,909 shares of BMY stock, worth $2.83 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

51,909

Previous 50,060 3.69%

Holding current value

$2.83 Million

Previous $2.59 Million 13.32%

% of portfolio

0.16%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$51.92 - $59.94 $96,000 - $110,829	1,849 Added 3.69%	51,909 $2.94 Million
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $185,013 - $241,413	4,665 Added 10.28%	50,060 $2.59 Million
Q2 2024 Jul 22, 2024	BUY	$40.25 - $52.99 $516,206 - $679,596	12,825 Added 39.38%	45,395 $1.89 Million
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $603,348 - $684,080	12,575 Added 62.89%	32,570 $1.77 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $236,000 - $281,613	-4,868 Reduced 19.58%	19,995 $1.03 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $580,463 - $649,047	-10,027 Reduced 28.74%	24,863 $1.44 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $1.59 Million - $1.77 Million	-25,000 Reduced 41.74%	34,890 $2.23 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $38,440 - $43,600	-585 Reduced 0.97%	59,890 $4.15 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $293,779 - $347,876	-4,290 Reduced 6.62%	60,475 $4.35 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $333 - $196,940	2,563 Added 4.12%	64,765 $4.6 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $1.11 Million - $1.22 Million	15,275 Added 32.55%	62,202 $4.79 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $543,421 - $651,611	-8,839 Reduced 15.85%	46,927 $3.43 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $519,138 - $605,193	-9,680 Reduced 14.79%	55,766 $3.48 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $42,188 - $49,418	713 Added 1.1%	65,446 $3.87 Million
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $321,622 - $350,246	5,195 Added 8.73%	64,733 $4.33 Million
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $215,463 - $242,332	3,631 Added 6.49%	59,538 $3.76 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $493,099 - $558,772	8,540 Added 18.03%	55,907 $3.47 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $101,076 - $112,006	1,760 Added 3.86%	47,367 $2.86 Million
Q2 2020 Jul 13, 2020	BUY	$54.82 - $64.09 $135,515 - $158,430	2,472 Added 5.73%	45,607 $2.68 Million
Q1 2020 Apr 08, 2020	BUY	$46.4 - $67.43 $265,732 - $386,171	5,727 Added 15.31%	43,135 $2.4 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $817,574 - $1.07 Million	16,614 Added 79.9%	37,408 $2.4 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $87,678 - $103,955	-2,050 Reduced 8.97%	20,794 $1.05 Million
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $328,403 - $363,142	-7,360 Reduced 24.37%	22,844 $1.04 Million
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $271,848 - $324,145	-6,025 Reduced 16.63%	30,204 $1.44 Million
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $159,689 - $207,078	-3,275 Reduced 8.29%	36,229 $1.88 Million
Q3 2018 Oct 09, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 0.5%	39,504 $2.45 Million
Q2 2018 Jul 10, 2018	BUY	$50.53 - $62.98 $5,053 - $6,298	100 Added 0.25%	39,704 $2.2 Million
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $29,960 - $34,490	-500 Reduced 1.25%	39,604 $2.51 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $55,444 - $60,448	-925 Reduced 2.25%	40,104 $2.46 Million
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $2.27 Million - $2.62 Million	41,029	41,029 $2.62 Million

Others Institutions Holding BMY

# of Institutions

2,745

Shares Held

1.57B

Call Options Held

27.9M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $116B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Account

Investment House LLC Bristol Myers Squibb CO Transaction History